FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1091-1093 April 10, 1997 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

During the past 50 years, mortality from acute bleeding in the upper gastrointestinal tract has remained at 6 to 10 percent, despite improved medical and surgical treatments, the development of diagnostic and therapeutic endoscopy, and the availability of intensive care units.¹ One contributing factor is that patients tend to be older and to have more coexisting illnesses than ever before.² The widespread use of aspirin and other nonsteroidal antiinflammatory agents, even at low doses taken to prevent cardiovascular disease, has also substantially increased the risk of bleeding.³

Fortunately, in 70 to 80 percent of patients with upper gastrointestinal bleeding, the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• (1997). OMEPRAZOLE FOR BLEEDING PEPTIC ULCER. JWatch General 1997: 1-1 [Full Text]